4D Pharma PLC (DDDD)

88.60
+1.20(+1.37%)
  • Volume:
    704,594
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    85.00 - 90.00

DDDD Overview

Prev. Close
87.4
Day's Range
85-90
Revenue
540K
Open
85
52 wk Range
48-183
EPS
-0.23
Volume
704,594
Market Cap
159.75M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,328,580
P/E Ratio
-
Beta
3.24
1-Year Change
72.37%
Shares Outstanding
180,300,967
Next Earnings Date
23 Sept 2021
What is your sentiment on 4D Pharma PLC?
or
Market is currently closed. Voting is open during market hours.

4D Pharma PLC News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuySellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuySellStrong Sell
SummaryStrong BuyStrong BuyStrong BuySellStrong Sell

4D Pharma PLC Company Profile

4D Pharma PLC Company Profile

Employees
92

4D pharma plc, together with its subsidiaries, engages in the research, development, and production of live biotherapeutic products. The company develops therapeutic candidates, such as MRx0518; MRx-4DP000 for the treatment of asthma and COVID-19; MRx0029 the treatment of central nervous system disorders; Blautix for irritable bowel syndrome; and Thetanix for pediatric crohn’s disease. It also develops products candidates, including MRx1299 for solid tumors, MRx0005 for neurodegeneration, MRx0006 for rheumatoid arthritis, and MRx0002 for multiple sclerosis. The company develops MicroRx platform to discover new LBP candidates for major diseases. 4D pharma plc has a collaboration agreement with Merck & Co., Inc. to conduct a clinical trial evaluating the combination of Keytruda and MRx0518 in patients with solid tumors. The company was formerly known as Schosween 18 Limited. 4D pharma plc was incorporated in 2014 and is headquartered in Leeds, the United Kingdom.

Read More
  • Bullish 100%
    0
    • Seems the bubble well and truly burst lol, expected a jump and got a puncture
      0
      • So much for the jump in share price after being listed on the NASDAQ
        2
        • Any news on the NASDAQ?
          1
          • Any more news on the stock appearing on the NASDAQ?
            0
            • Is this stock worth holding or sell now?
              0
              • Hold- new NASDAQ listing should help boost the shareprice. looking for 2.50 minimum for these shares
                0
              • Calum Burnsthank you, really appreciated
                0
            • Supposedly hitting the NASDAQ sometime is Q1
              0
              • Is it worth holding on to or sell on?
                0
            • Looking forward to see 4D get a boost when it appears on NASDAQ
              0
              • Any ideas when this is supposed to happen?
                0
              • When roughly?
                0
            • Any news on this stock rising at any time?
              0
              • I heard 4d were up to something and something was going to be announced today. Rotten deal. and an extra $14 m will last them a few months I suppose. still no where near enough for phase 3 trials.
                1
                • Anyone know how they are going to raise more money? placing or Nasdaq IPO?
                  0
                  • Why the sudden drop?
                    1
                    • Blautix results were just above average. To be honest , Duncan said said he was "hopeful" on Blautix in his last interview so not a real surprise the SP has dropped
                      0
                    • Pro Fessorthank you 👍🏻
                      1
                  • I bought 4D on an impulse at the checkout without doing h/w. SP was reduced (yellow label). Would someone please tell me why I should hold and what to expect in the next few months. Is this a pure pharma play? I prefer to hold if there are prospects. Trading is hard work for an old man.
                    0
                    • Recommend you do your homework! Read the last RNS from company yesterday. (30/9/20). Clinical trail results expected first few days of October and has the potential to be the worlds first disease modifying therapy for IBS!!!! Game changer for this company IMO.
                      1
                    • Nav Akbar Thanks Nav. Good to know. BB chat sometimes provide an informed view of dry facts. Some facts are more equal than others.
                      0
                    • ***happened? 170p to 100p? "game changing" for the SP indeed !
                      0
                  • Is the rise over or will this go to £2, any thoughts?
                    1
                    • After consolidation, time will tell
                      1
                    • Addul, you are talking about  company which can effectively treat the root cause of cancer.   2 pounds will be nothing in years time.   With a  NASDAQ listing this year , the will be an IPO valuation north of 1 bill GBP min. IMO
                      0
                    • *there
                      0
                  • Outstanding news today, hence the rise. This will only go up!
                    1
                    • 4D will go up by £2 very soon. great news will come soon get ready to make bundle
                      2
                      • What gives you that idea/impression?
                        0
                    • Any thoughts on where this stock is heading?
                      0
                      • 40p
                        3
                    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.